Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Study of Fasiglifam (TAK-875)
NCT01433419Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jan 2012; status: completed.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01433419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433419.